These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10959506)

  • 21. Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: a subanalysis of the Coronary Artery Revascularization Prophylaxis (CARP) trial.
    Raghunathan A; Rapp JH; Littooy F; Santilli S; Krupski WC; Ward HB; Thottapurathu L; Moritz T; McFalls EO;
    J Vasc Surg; 2006 Jun; 43(6):1175-82. PubMed ID: 16765234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study.
    Ramaswami G; D'Ayala M; Hollier LH; Deutsch R; McElhinney AJ
    J Vasc Surg; 2005 May; 41(5):794-801. PubMed ID: 15886663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rehabilitation program in patients with moderate-to-severe intermittent claudication: immediate results and one year follow-up].
    Rossini D; Bulckaen M; Di Marco S; Giovannetti R; Giuntoli F; Lacopetti L; Vergoni W
    Monaldi Arch Chest Dis; 2007 Jun; 68(2):110-4. PubMed ID: 17886772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular and orbital blood flow velocity in patients with peripheral vascular disease and diabetes treated with intravenous prostaglandin E1.
    Steigerwalt RD; Belcaro GV; Christopoulos V; Incandela L; Cesarone MR; De Sanctis MT
    J Ocul Pharmacol Ther; 2001 Dec; 17(6):529-35. PubMed ID: 11777176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudication.
    Creutzig A; Bullinger M; Cachovan M; Diehm C; Forst HT; Gruss JD; Horsch S; Rogatti W; Scheffler P; Spengel F; Stiegler H
    Vasa; 1997 May; 26(2):122-7. PubMed ID: 9174389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E; Bahnini A; Mouren X; Gamand S
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of intra-arterial administration of PGE1 prostaglandin].
    Ciostek P; Kostewicz W; Górski G
    Wiad Lek; 1994 Oct; 47(19-20):750-2. PubMed ID: 7483622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF; Davie AM; Clegg JP
    Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined percutaneous endovascular iliac angioplasty and infrainguinal surgical revascularization for chronic lower extremity ischemia: preliminary result.
    Mousa A; Abdel-Hamid M; Ewida A; Saad M; Sahrabi A
    Vascular; 2010; 18(2):71-6. PubMed ID: 20338130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sirolimus for below the knee lesions: mid-term results of SiroBTK study.
    Commeau P; Barragan P; Roquebert PO
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):793-8. PubMed ID: 17039538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin E1 -containing nanoparticles improve walking activity in an experimental rat model of intermittent claudication.
    Ishihara T; Yamashita Y; Takasaki N; Yamamoto S; Hayashi E; Tahara K; Takenaga M; Yamakawa N; Ishihara T; Kasahara T; Mizushima T
    J Pharm Pharmacol; 2013 Aug; 65(8):1187-94. PubMed ID: 23837586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and microcirculatory effects of transcutaneous CO2 therapy in intermittent claudication. Randomized double-blind clinical trial with a parallel design.
    Fabry R; Monnet P; Schmidt J; Lusson JR; Carpentier PH; Baguet JC; Dubray C
    Vasa; 2009 Aug; 38(3):213-24. PubMed ID: 19736632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PGE(1) short term therapy in critical lower limb ischemia.
    Bandiera G; Forletta M; Di Paola FM; Cirielli C
    Int Angiol; 2003 Mar; 22(1):58-63. PubMed ID: 12771858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Midterm results of prostaglandin E1 treatment in patients with lumbar spinal canal stenosis accompanied by intermittent claudication.
    Nakanishi K; Tanaka M; Misawa H; Takigawa T; Ozaki T
    Spine (Phila Pa 1976); 2008 Jun; 33(13):1465-9. PubMed ID: 18520942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease.
    Kalbaugh CA; Taylor SM; Blackhurst DW; Dellinger MB; Trent EA; Youkey JR
    J Vasc Surg; 2006 Aug; 44(2):296-302; discussion 302-3. PubMed ID: 16814976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of cutaneous necrosis risk in peripheral arterial diseases].
    D'Eri A; Martini R; Cordova RM; Trevisan G; Andreozzi GM
    Minerva Cardioangiol; 2002 Jun; 50(3):239-44. PubMed ID: 12107403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Double-blind study of the effect of dipyridamole in patients with intermittent claudication].
    Baumgartner I; Schalch I; Bollinger A
    Vasa; 1992; 21(4):387-91. PubMed ID: 1485474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health-related quality of life after revascularization for peripheral arterial occlusive disease: long-term follow-up.
    Wann-Hansson C; Hallberg IR; Risberg B; Lundell A; Klevsgard R
    J Adv Nurs; 2005 Aug; 51(3):227-35. PubMed ID: 16033590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of peripheral and cardiopulmonary performance after a short-term exercise program with additive prostaglandin E1.
    Cachovan M; Rogatti W
    Angiology; 2001 Jun; 52(6):381-91. PubMed ID: 11437028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.